Cumulative operating cash flow of $15.4B exceeded net income of $14.4B over ten quarters, but 2026Q4 OCF/NI fell to 0.64 with a $1.0B working capital outflow, highlighting quarterly cash conversion volatility.
Lam Research Corporation (LRCX) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Jun'26 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 |
|---|
| Cash from Operations | 5.86B | 6.17B | 4.65B | 5.18B | 3.1B | 3.59B | 2.13B | 3.18B | 2.66B | 2.03B | 1.35B | 785.5M | 717.05M | 719.93M | 499.03M | 881.03M | 350.71M | -78.13M | 590.32M | 823.56M | 360.69M | 425.93M | 157.15M | 69.24M | 21.8M | 261.29M | 119.85M | -37.22M | 51.24M | 80.17M |
| Operating CF Margin % | 25.21% | 33.49% | 31.21% | 29.72% | 17.99% | 24.53% | 21.17% | 32.9% | 23.98% | 25.32% | 22.94% | 14.94% | 15.56% | 20% | 18.72% | 27.21% | 16.44% | -7% | 23.85% | 32.09% | 21.96% | 28.35% | 16.79% | 9.17% | 2.31% | 17.19% | 9.74% | -5.74% | 4.87% | 8% |
| Operating CF Growth % | -5.11% | 32.69% | -10.17% | 67.08% | -13.61% | 68.74% | -33.05% | 19.59% | 30.87% | 50.29% | 71.9% | 9.55% | -0.4% | 44.27% | -43.36% | 151.21% | 548.89% | -113.23% | -28.32% | 128.33% | -15.32% | 171.04% | 126.96% | 217.67% | -91.66% | 118.01% | 422.05% | -172.62% | -36.08% | 201.25% |
| Net Income | 7.27B | 5.36B | 3.83B | 4.51B | 4.61B | 3.91B | 2.25B | 2.19B | 2.38B | 1.7B | 914.05M | 655.58M | 632.29M | 113.88M | 168.72M | 723.75M | 346.67M | -302.15M | 439.35M | 685.82M | 335.75M | 299.34M | 82.99M | -7.74M | -90.05M | 52.11M | 204.76M | -112.91M | -144.6M | -33.63M |
| Depreciation & Amortization | 441.53M | 386.28M | 359.7M | 342.43M | 333.74M | 307.15M | 268.52M | 309.28M | 326.39M | 306.9M | 291.03M | 277.92M | 292.25M | 304.12M | 100.83M | 74.76M | 71.4M | 72.42M | 54.7M | 37.44M | 24.68M | 29.67M | 35.37M | 44.97M | 64.34M | 58.73M | 46.02M | 50.92M | 62.27M | 53.11M |
| Stock-Based Compensation | 386.38M | 343.37M | 293.06M | 286.6M | 259.06M | 220.16M | 189.2M | 187.23M | 172.22M | 149.97M | 142.35M | 135.35M | 103.7M | 99.33M | 81.56M | 53.01M | 50.46M | 53.04M | 42.52M | 22.77M | 22.77M | 864K | 3.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -289.06M | -363.25M | -198.98M | -172.06M | -257.44M | -151.48M | -17.78M | -4.98M | 3.05M | 104.94M | -49M | 5.55M | 7.54M | -70.16M | 42.45M | 18.05M | 13.72M | 30.55M | -26.66M | 17.05M | 27.73M | 89.35M | 10.86M | -8.64M | -34.17M | -7.03M | 18.57M | -3.51M | -25.69M | -24.44M |
| Other Non-Cash Items | -32.71M | 6.84M | 10.24M | 52.3M | -44.75M | -17.39M | 6.63M | 1.52M | 90.6M | 80.53M | 104.08M | 131.96M | -25.82M | 72.53M | 39.32M | -10.5M | 28.34M | 163.09M | 6.39M | 31.52M | 9.65M | 14.96M | -490K | 33.99M | 108.25M | 113.36M | -23.15M | 39.14M | 103.64M | 0 |
| Working Capital Changes | -1.91B | 441.8M | 360.48M | 158.74M | -1.8B | -678.74M | -571.88M | 491.52M | -317.19M | -310.83M | -52.23M | -420.86M | -292.91M | 200.24M | 66.16M | 21.95M | -159.88M | -95.08M | 74.03M | 28.96M | -59.9M | -8.25M | 25.25M | 6.67M | -26.57M | 44.12M | -126.34M | -10.86M | 55.62M | 85.13M |
| Change in Receivables | 0 | -858.75M | 303.44M | 1.45B | -1.29B | -928.93M | -641.83M | 732.14M | -501.63M | -411.29M | -169.03M | -294.15M | -201.55M | 162.63M | 66.06M | -89.72M | -246.65M | 152.09M | 99.89M | -178.54M | -178.54M | 13.47M | -297.05M | 44.47M | 118.25M | 68.56M | -150.82M | -502K | 51.8M | 39.04M |
| Change in Inventory | 0 | -180.73M | 528.72M | -961.97M | -1.35B | -792.59M | -411.61M | 281.36M | -701.01M | -307.88M | -66.37M | -207.46M | -190.06M | 76.35M | 73.99M | -77.46M | -79.7M | 46.05M | 19.68M | -56.34M | -59.04M | -2.59M | 5.14M | 63.45M | 96.51M | -73.12M | -44.8M | 33.73M | 4.47M | 60.93M |
| Change in Payables | 0 | 212M | 125.94M | -522.2M | 167.88M | 184.62M | 208.48M | -131.47M | 35.66M | 126.82M | 41.65M | 76.62M | 18.7M | -58.08M | 12.14M | 42.32M | 71.6M | -39.38M | -40.13M | 48.34M | 48.34M | -33.11M | 57.85M | 5.24M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -922.15M | -708.09M | -370.61M | -534.56M | 612.27M | 73.27M | -244.08M | -1.64B | 2.75B | -2.06B | 592.48M | -1.11B | -265.21M | -238.64M | 269.73M | -479.91M | -103.36M | 6M | -495.81M | -82.85M | -244.29M | -58.73M | 48.51M | 296.36M | -88.13M | -427.54M | -91.74M | 69.96M | -438.63M | -22.16M |
| Capital Expenditures | -966.4M | -759.19M | -396.67M | -501.57M | -546.03M | -349.1M | -203.24M | -303.49M | -273.47M | -157.42M | -175.33M | -198.26M | -145.5M | -160.79M | -107.27M | -127.5M | -35.59M | -44.28M | -76.8M | -59.97M | -42.08M | -22.85M | -24.03M | -12.26M | -10.62M | -64.39M | -50.36M | -33.18M | -50.21M | -39.55M |
| CapEx % of Revenue | 4.16% | 4.12% | 2.66% | 2.88% | 3.17% | 2.39% | 2.02% | 3.14% | 2.47% | 1.96% | 2.98% | 3.77% | 3.16% | 4.47% | 4.02% | 3.94% | 1.67% | 3.97% | 3.1% | 2.34% | 2.56% | 1.52% | 2.57% | 1.62% | 1.13% | 4.24% | 4.09% | 5.12% | 4.77% | 3.95% |
| Acquisitions | 0 | 0 | 0 | -119.95M | 0 | 349.1M | 203.24M | 303.49M | -115.7M | 157.42M | 175.33M | 40.08M | -30.23M | -9.92M | 418.68M | -209.42M | 35.59M | -19.46M | -482.57M | -181.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 44.25M | 51.09M | -11.71M | 86.96M | -7.58M | -391.25M | -229.08M | -1.91B | 2.52B | -2.87B | 668.65M | -2.13B | -833.8M | -1.05B | -830.39M | -22K | -36.39M | -100.58M | 44.75M | 110M | -385M | 27.43M | 5.6M | 617K | -1.61M | -21.91M | -13.55M | -6.67M | -59.6M | -11.7M |
| Cash from Financing | -5.72B | -4.94B | -4B | -2.83B | -4.58B | -4.17B | -623.93M | -2.39B | -3.27B | -2.63B | 1.6B | 378.47M | -162.74M | -887.79M | -692.75M | 526.99M | -72.66M | -260.83M | 65.81M | -1.08B | 310.69M | -52.32M | -211.75M | -373.35M | 16.3M | 321.85M | 8.38M | -8.29M | 260.02M | 4.84M |
| Debt Issued (Net) | -755.43M | -507.49M | -256.1M | -23.21M | -11.89M | -862.06M | 1.31B | 2B | -396.09M | -1.69B | 1.89B | 990.71M | -1.66M | -2.23M | -5.26M | 878.3M | -20.7M | -255.42M | 201K | -100.17M | 349.52M | 0 | -300.01M | -361.41M | -8.69M | 335.73M | -20.4M | -7.07M | 239.82M | -8.61M |
| Equity Issued (Net) | -3.83B | -3.28B | -2.83B | -2.01B | -3.86B | -2.67B | -1.37B | -3.77B | -2.64B | -739.1M | -158.39M | -573.24M | -210.07M | -916.28M | -715.69M | -348.5M | -62.19M | 865K | 6.71M | -1.02B | -56.64M | -52.32M | 77.39M | -11.94M | 25M | -13.88M | 28.78M | -493K | 20.21M | 13.45M |
| Dividends Paid | -1.27B | -1.15B | -1.02B | -907.91M | -815.29M | -726.99M | -656.84M | -678.35M | -307.61M | -243.5M | -190.4M | -116.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.85B | -3.42B | -2.84B | -2.02B | -3.87B | -2.7B | -1.37B | -3.78B | -2.65B | -811.67M | -158.39M | -573.24M | -244.86M | -955.66M | -772.66M | -211.32M | -93.03M | -30.95M | -14.55M | -1.08B | -251.21M | -167.08M | 0 | -39.12M | -10.68M | -45.07M | -31.58M | -18.9M | 0 | 0 |
| Other Financing | 142.17M | 143K | 106.42M | 106.35M | 108.22M | 95.65M | 95.44M | 64.75M | 75.63M | 38.51M | 57.89M | 77.06M | 48.99M | 30.73M | 28.21M | -2.81M | 10.23M | -6.27M | 58.9M | 44.99M | 17.8M | 0 | 10.87M | 0 | 0 | 0 | 0 | -727K | 0 | 0 |
| Net Change in Cash | -809.71M | 556.85M | 263.43M | 1.81B | -897.22M | -498.33M | 1.26B | -855.16M | 2.13B | -2.66B | 3.54B | 48.86M | 290.2M | -402.28M | 72.62M | 946.37M | 171.6M | -358.37M | 158.57M | -336.85M | 428.56M | 318.85M | -3.94M | -5.09M | -49.23M | 151.6M | 32.09M | 24.46M | -127.36M | 62.85M |
| Free Cash Flow | 4.89B | 5.41B | 4.26B | 4.68B | 2.55B | 3.24B | 1.92B | 2.87B | 2.38B | 1.87B | 1.17B | 587.24M | 571.55M | 559.14M | 391.76M | 753.53M | 315.12M | -122.41M | 513.52M | 763.59M | 318.61M | 403.08M | 133.12M | 56.98M | 11.18M | 196.89M | 69.49M | -70.4M | 1.04M | 40.62M |
| FCF Margin % | 21.05% | 29.37% | 28.55% | 26.84% | 14.82% | 22.15% | 19.15% | 29.76% | 21.51% | 23.36% | 19.96% | 11.17% | 12.41% | 15.54% | 14.7% | 23.27% | 14.77% | -10.97% | 20.75% | 29.75% | 19.4% | 26.83% | 14.22% | 7.54% | 1.19% | 12.96% | 5.65% | -10.86% | 0.1% | 4.05% |
| FCF Growth % | -9.66% | 27.22% | -9.02% | 83.16% | -21.16% | 68.42% | -33.05% | 20.58% | 27.27% | 59.31% | 100.08% | 2.75% | 2.22% | 42.73% | -48.01% | 139.12% | 357.43% | -123.84% | -32.75% | 139.67% | -20.96% | 202.79% | 133.64% | 409.73% | -94.32% | 183.34% | 198.71% | -6882.08% | -97.44% | 201.6% |
| FCF per Share | 3.88 | 4.20 | 3.22 | 3.44 | 1.82 | 2.23 | 1.29 | 1.80 | 1.32 | 1.02 | 0.67 | 0.33 | 0.33 | 0.32 | 0.31 | 0.60 | 0.25 | -0.10 | 0.41 | 0.54 | 0.22 | 0.28 | 0.09 | 0.05 | 0.01 | 0.15 | 0.05 | -0.06 | 0.00 | 0.04 |
| FCF Conversion (FCF/Net Income) | 0.81x | 1.15x | 1.22x | 1.15x | 0.67x | 0.92x | 0.94x | 1.45x | 1.12x | 1.20x | 1.48x | 1.20x | 1.13x | 6.32x | 2.96x | 1.22x | 1.01x | 0.26x | 1.34x | 1.20x | 1.07x | 1.42x | 1.89x | -8.95x | -0.24x | 5.01x | 0.59x | 0.33x | -0.35x | -2.38x |
| Interest Paid | 0 | 172.35M | 173.09M | 174.75M | 175.53M | 203.93M | 171.89M | 76.93M | 84.4M | 104.62M | 58.81M | 26.39M | 26.49M | -26.64M | -8.25M | -232K | 878K | 7.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 972.51M | 991.82M | 809.75M | 807.67M | 518.57M | 222.91M | 300.27M | 142.8M | 28.1M | 39.74M | 114.51M | 18.16M | -7.7M | -29.11M | -70.77M | 16.26M | 33.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying LRCX stock.
Lam Research Corporation (LRCX) generated $5.86B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.
Lam Research Corporation (LRCX) generated $4.89B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Lam Research Corporation (LRCX) spent $966.4M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2026, Lam Research Corporation (LRCX) returned $1.27B to shareholders via cash dividends and spent $3.85B on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
China concentration and EPS miss
Metrics are mathematically derived from official filings.
Cash Conversion Volatility Amidst Growth
LRCX's OCF/NI ratio swung from 1.48 in 2025Q4 to 0.64 in 2026Q4, per reported cash flow data, indicating significant working capital drag despite record net income.
The sharp decline in cash conversion from 1.48 to 0.64 over four quarters suggests that earnings are increasingly tied up in working capital, particularly inventory and receivables, rather than being converted to cash. This pattern may reflect customer acceptance delays or channel stocking, which warrants monitoring as it could signal a temporary timing issue or a more persistent deterioration in cash generation quality.
FCF Margin Expansion on AI Demand
Free cash flow margin improved from 19.7% in 2024Q4 to 46.1% in 2025Q4, but fell to 12.2% in 2026Q4, as per cash flow statements, reflecting cyclicality and working capital swings.
The FCF margin trajectory shows a dramatic peak in 2025Q4 followed by a sharp contraction, driven by a $1.0B working capital outflow in 2026Q4. This volatility suggests that while the underlying business is highly cash-generative, near-term FCF is heavily influenced by timing of collections and inventory builds. Investors should focus on the multi-quarter average rather than a single quarter, as the 2026Q4 dip may be a temporary disruption amid record revenue.
Capital Intensity Remains Low
CapEx as a percentage of revenue averaged 4.2% over the last ten quarters, per reported data, indicating a capital-light model with minimal maintenance capex requirements.
With CapEx/Rev consistently below 10% and often around 3-6%, LRCX's capital intensity is remarkably low for a manufacturing firm, reflecting its asset-light model focused on R&D and assembly rather than heavy fabrication. This allows for high FCF conversion, but the low maintenance capex also implies that the company's competitive edge relies more on intangible assets like intellectual property and process know-how, which are not captured in the cash flow statement.
Working Capital Swings Signal Timing Risks
Working capital changes swung from +$778.8M in 2025Q4 to -$1.0B in 2026Q4, as per cash flow data, indicating significant volatility in cash conversion cycles.
The large swings in working capital, particularly the $1.0B outflow in 2026Q4, suggest that LRCX is experiencing timing differences between shipments and customer acceptances, possibly due to complex AI-related tool installations. This pattern may indicate that revenue recognition is outpacing cash collections, which could be a leading indicator of future cash flow normalization. Monitoring days sales outstanding and inventory levels will be critical to assess whether this is a one-off or a trend.
Aggressive Capital Return Continues
LRCX returned $2.1B to shareholders in 2026Q4 via dividends and buybacks, per cash flow data, exceeding its FCF of $822M, indicating reliance on cash reserves.
The company's capital return program is substantial, with buybacks and dividends consistently exceeding FCF in recent quarters, funded by its $6.39B cash balance. While this demonstrates management's confidence in future cash generation, it also reduces financial flexibility and may not be sustainable if cash conversion remains weak. The low debt-to-equity ratio of 0.48% provides a cushion, but investors should monitor whether capital returns are being funded by debt or cash reserves.
Cumulative Cash Generation Outpaces Earnings
Over the last ten quarters, cumulative operating cash flow of $15.4B exceeded net income of $14.4B, per reported data, indicating high earnings quality despite quarterly volatility.
The cumulative OCF/NI ratio of 1.07 over the period suggests that, on a multi-quarter basis, LRCX's earnings are well-supported by cash generation, with non-cash items like D&A and SBC adding back more than working capital drains. This long-term alignment between earnings and cash flow supports the quality of reported profits, even though quarterly fluctuations can be misleading. The divergence in individual quarters, such as 2026Q4, appears to be timing-related rather than a fundamental deterioration.
What Could Invalidate the Base Case
Despite record revenue, the 2026Q4 OCF/NI ratio of 0.64 and a $1.0B working capital outflow, per cash flow data, may signal channel stuffing or acceptance delays that could reverse.
The cash flow statement obscures potential issues such as aggressive revenue recognition on customer acceptance terms, which may inflate earnings relative to cash. The significant working capital outflow in 2026Q4, combined with the EPS miss, suggests that some revenue may not be converting to cash as quickly as expected, possibly due to evaluation units or extended payment terms. Investors should scrutinize deferred revenue and inventory levels in the next filings to determine if this is a timing issue or a more concerning trend.